BridgeMD
New treatment option for Mild Cognitive Impairment
Official title Spatial Memory Training and Cognitive Function
ClinicalTrials.gov ID: NCT07002996
What this study is testing
- What it's testing
- Mild cognitive impairment (MCI) is often considered a transitional stage between normal aging and dementia, particularly Alzheimer's disease (AD). Patients with MCI have subjective memory complaints corroborated by standard neuropsychological tests but remain functionally autonomous.
- You might receive a placebo (an inactive treatment) instead of the study drug, decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 55 and older
You may be able to join if
- Age 55 years and above.
- Primary language is English or French.
- Individuals having received a diagnosis of Mild Cognitive Impairment (MCI).
You likely can't join if
- Self-reported having either of the following: Current post-traumatic stress disorder and/or generalized anxiety disorder; Substance use disorder...
- Current medications for sleep problems, or use of medications that affect sleep.
- Use of antidepressant and anti-anxiety medication for less than 3 months prior to study entry.
- Use of analgesics with codeine (or other opioids).
- Use of antipsychotic medication (past or current).
- Having undergone brain surgery or ECT.
See the full eligibility criteria
- Age 55 years and above.
- Primary language is English or French.
- Individuals having received a diagnosis of Mild Cognitive Impairment (MCI).
- Self-reported having either of the following: Current post-traumatic stress disorder and/or generalized anxiety disorder; Substance use disorder; Significant heart disease (i.e., stroke occurring during 5 years prior to...
- Current medications for sleep problems, or use of medications that affect sleep.
- Use of antidepressant and anti-anxiety medication for less than 3 months prior to study entry.
- Use of analgesics with codeine (or other opioids).
- Use of antipsychotic medication (past or current).
- Having undergone brain surgery or ECT.
- Self-reported colour-blindness.
- General anesthesia in the past year.
- Current smoker.
- Suspected or confirmed traumatic brain injury during the last 24 months.
- Motion sickness or intolerant to virtual reality tasks.
- Cholesterol or hypertension medication for less than 3 months or changes expected within the next 9 months.
- History or presence of neurological or psychiatric disorders (other than MCI) that in the opinion of the investigator may compromise patient safety or study objectives.
- Current severe medical conditions (e.g. untreated diabetes, cancer) that in the opinion of the investigator may compromise patient safety or study objectives.
- For female participants, severe menopausal symptoms, including hot flashes (determined from the Greene climacteric scale - any participants scoring over 15 is excluded).
- Use of computer games that are designed to help with memory or general cognition.
- Presence of any medical or psychological condition that, in the opinion of the principal investigator, may compromise the study objectives.
- Presence of contra-indications for MRI scanning.
The study team makes the final eligibility decision.
Where it's taking place
- Verdun, Quebec, Canada
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 55 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Verdun, Quebec, Canada. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.